3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Hepatocellular
9
Squamous Cell Carcinoma of Head and Neck
4
Nasopharyngeal Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Non-Small-Cell Lung
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Stomach Neoplasms
3
Esophageal Neoplasms
3
Pancreatic Neoplasms
2
Locally Advanced Rectal Cancer
2
Colonic Neoplasms
2
Cervical Cancer Metastatic
2
Breast Neoplasms
2
Adenocarcinoma
2
Turcot syndrome
1
Salivary Gland Neoplasms
1
Recurrence
1
Rectal Cancer Patients
1
Non-squamous Non-small-cell Lung Cancer
1
Mouth Neoplasms
1
Liver Neoplasms
1
Leukemia, Myeloid, Acute
1
Laryngeal Neoplasms
1
Gestational Trophoblastic Disease
1
Esophageal Squamour Cell Cancer
1
Endometrioid Endometrial Cancer
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Advanced Primary Liver Cancer
1
Interventions
pembrolizumab
44
Gemcitabine
23
enfortumab vedotin
21
Nivolumab
20
Cisplatin
17
avelumab
16
Magnetic Resonance Spectroscopy
15
Carboplatin
14
atezolizumab
13
Specimen Handling
12
Docetaxel
11
sacituzumab govitecan
9
Paclitaxel
8
Ipilimumab
8
durvalumab
6
Mitomycin
5
Fluorodeoxyglucose F18
5
cabozantinib
4
Taxes
4
toripalimab
3
pemigatinib
3
erdafitinib
3
X-Rays
3
Radiosurgery
3
Platinum
3
Pemetrexed
3
Immunoglobulin G
3
CTLA-4 Antigen
3
Biopsy
3
ALT-803
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Transitional Cell
×
camrelizumab
×
1 year
×
Clear all
No trials found.